Hemenway Trust Co LLC Decreases Stake in Roche Holding AG (OTCMKTS:RHHBY)

Hemenway Trust Co LLC lowered its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 61.0% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,006 shares of the company’s stock after selling 10,975 shares during the quarter. Hemenway Trust Co LLC’s holdings in Roche were worth $243,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of RHHBY. Bard Financial Services Inc. raised its position in Roche by 2.0% in the first quarter. Bard Financial Services Inc. now owns 20,200 shares of the company’s stock worth $645,000 after acquiring an additional 400 shares during the period. SVB Wealth LLC lifted its stake in Roche by 2.6% in the first quarter. SVB Wealth LLC now owns 16,646 shares of the company’s stock valued at $531,000 after purchasing an additional 426 shares during the last quarter. Confluence Investment Management LLC grew its holdings in Roche by 3.7% during the second quarter. Confluence Investment Management LLC now owns 12,922 shares of the company’s stock valued at $448,000 after purchasing an additional 459 shares during the period. Norman Fields Gottscho Capital Management LLC increased its position in Roche by 2.3% in the second quarter. Norman Fields Gottscho Capital Management LLC now owns 24,650 shares of the company’s stock worth $858,000 after buying an additional 550 shares during the last quarter. Finally, Archer Investment Corp raised its stake in shares of Roche by 10.6% in the second quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock valued at $236,000 after buying an additional 652 shares during the period.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Roche from a “sell” rating to a “hold” rating in a research report on Friday, May 17th. The Goldman Sachs Group assumed coverage on shares of Roche in a research note on Thursday, May 30th. They issued a “sell” rating for the company. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to MarketBeat, Roche currently has a consensus rating of “Hold” and an average price target of $40.00.

Roche Stock Down 0.8 %

OTCMKTS:RHHBY traded down $0.31 during midday trading on Friday, reaching $40.64. 1,738,099 shares of the stock traded hands, compared to its average volume of 2,305,609. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $42.43. The company has a current ratio of 1.35, a quick ratio of 1.04 and a debt-to-equity ratio of 0.75. The company has a fifty day moving average of $39.02 and a 200 day moving average of $34.55.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.